☰
Companies
▾
Companies
Calendar
Valuation
Screener
▾
Screener
Sectors
Magic Formula
Bubble Plot
Treemap
Chart Builder
Analysis
▾
Margins
Dividends
Buybacks
Countries
US vs EU P/E
IPO Tracker
Insider Buying
CEO Changes
M&A Tracker
Short Selling
Fear & Greed
AI Models
Leverage
Repo Market
Mortgage Delinquency
Private Credit
AI Capex
US Federal Debt
Macro
▾
EU Yield Curve
US Yield Curve
Health
▾
Diabetes
Immunology
Portfolio
▾
Portfolio
Berkshire
Buffett
More
▾
Denmark
Danish Tax
Tesla
EU XBRL Tables
Contact
Obesity
Blog
Arbutus Biopharma Corp
ABUS
☆
Healthcare
·
USA
·
USD
·
arbutusbio.com
Fundamentals
ROA
-35.41%
ROE
-43.7%
Net Margin
-90.9%
Rev Growth
128.2%
Valuation
Market Cap
924M USD
Fwd P/E
-
Div Yield
-
Financial Data
#
Annual
Quarterly
TTM
Income Statement
Margins
Cash Flow
Balance Sheet
Shares
Segment Breakdown
#
Multiples
#
P/S
P/E
1Y
2Y
5Y
10Y
All
Peers
#
DSGN
OLMA
GERN
CADL
KURA
TBPH
JANX
ANNX
ACRS
LXRX
·
Compare in Screener
Dividends
Bubble
Gross Margin
Net Margin
Fwd P/E
ROIC
Capex Intensity
Rev. Growth
Growth vs Margin
Chief Executives
#
Events
#
All
Insider
Earnings
Dividends
Date
Type
Details
Price
Amount
See also:
Healthcare in Screener
Treemap - USA
USA in Screener